Journal of Clinical Pharmacy & Therapeutics

Optimal therapy for reduction of lipoprotein(a)
pp. 1-3(3)
Authors: Lippi, G.; Targher, G.

The evolving understanding of the analgesic mechanism of action of flupirtine
pp. 4-6(3)
Authors: Raffa, R. B.; Pergolizzi Jr, J. V.

The intended and unintended consequences of benzodiazepine monitoring programmes: a review of the literature
pp. 7-21(15)
Authors: Fisher, J.; Sanyal, C.; Frail, D.; Sketris, I.

Effect of vitamins C and E on antioxidant status of breast-cancer patients undergoing chemotherapy
pp. 22-26(5)
Authors: Suhail, N.; Bilal, N.; Khan, H. Y.; Hasan, S.; Sharma, S.; Khan, F.; Mansoor, T.; Banu, N.

Efficacy of oxycodone/paracetamol for patients with bone-cancer pain: a multicenter, randomized, double-blinded, placebo-controlled trial
pp. 27-31(5)
Authors: Sima, L.; Fang, W. X.; Wu, X. M.; Li, F.

Analysis of antibiotic utilization and bacterial resistance changes in a surgical clinic of Clinical Centre, Nis
pp. 32-36(5)
Authors: Velickovic-Radovanovic, R.; Petrovic, J.; Kocic, B.; Antic, S.; Mitic, R.

Socio-demographic differences in adherence to evidence-based drug therapy after hospital discharge from acute myocardial infarction: a population-based cohort study in Rome, Italy
pp. 37-44(8)
Authors: Kirchmayer, U.; Agabiti, N.; Belleudi, V.; Davoli, M.; Fusco, D.; Stafoggia, M.; Arcà, M.; Barone, A. P.; Perucci, C. A.

Miconazole and nystatin used as topical antifungal drugs interact equally strongly with warfarin
pp. 45-48(4)
Authors: Kovac, M.; Mitic, G.; Kovac, Z.

Renal impairment after laparoscopic radical nephrectomy affects hypoglycaemic therapy
pp. 49-52(4)
Authors: Mizuno, T.; Ito, K.; Miyagawa, Y.; Kimura, K.; Suzuki, Y.; Mizuno, M.; Ito, Y.; Funahashi, Y.; Hattori, R.; Gotoh, M.; Noda, Y.; Yamada, K.

Content variability of active drug substance in compounded oral 3,4-diaminopyridine products
pp. 53-57(5)
Authors: Green, D. M.; Jones, A. C.; Brain, K. R.

Impact of out-of-pocket expenses on discontinuation of statin therapy: a cohort study in Finland
pp. 58-64(7)
Authors: Helin-Salmivaara, A.; Korhonen, M.J.; Alanen, T.; Huupponen, R.

Thiazolidenediones induce tumour-cell apoptosis through the Akt-GSK3β pathway
pp. 65-70(6)
Authors: Zhu, H.; Han, B.; Pan, X.; Qi, H.; Xu, L.

A stability indicating assay for a combination of morphine sulphate with levomepromazine hydrochloride used in palliative care
pp. 71-73(3)
Authors: Al-Tannak, N. F.; Cable, C. G.; McArthur, D. A.; Watson, D. G.

Influence of calcium channel blockers in patients with gastrointestinal disease in Japanese community pharmacies
pp. 74-77(4)
Authors: Hamada, A.; Akiyoshi, R.; Ishii, J.; Hamada, N.; Miyazaki, C.; Hamada, T.; Ohwaki, Y.; Ikeda, R.; Wada, M.; Nakashima, K.

Consumption of three most widely used analgesics in six European countries
pp. 78-80(3)
Authors: Hudec, R.; Božeková, L.; Tisoňová, J.

Evaluation of steady-state pharmacokinetic interactions between ritonavir-boosted BILR 355, a non-nucleoside reverse transcriptase inhibitor, and lamivudine/zidovudine in healthy subjects
pp. 81-88(8)
Authors: Huang, F.; Allen, L.; Huang, D. B.; Moy, F.; Vinisko, R.; Nguyen, T.; Rowland, L.; MacGregor, T. R.; Castles, M. A.; Robinson, P.

Rapid and validated fluorometric HPLC method for determination of gabapentin in human plasma and urine for clinical application
pp. 89-94(6)
Authors: Yagi, T.; Naito, T.; Mino, Y.; Takashina, Y.; Umemura, K.; Kawakami, J.

The effects of food on the pharmacokinetics of mitiglinide tablets in healthy volunteers and a novel mass-spectrometric (UPLC-MS/MS) method for such studies
pp. 95-99(5)
Authors: Zhang, J.; Cai, L.-J.; Peng, W.-X.; Zhu, R.-H.; Yang, J.; Zhang, Q.-Z.

Cytochrome <i>P450 3A4</i> genetic polymorphisms and post-operative fentanyl requirements
pp. 100-104(5)
Authors: Tan, P. C. S.; Hassan, S. K.; Mohamad, N. A. N.; Gan, S. H.

Frequency of <i>CYP2C9</i> variant alleles, including <i>CYP2C9*13</i> in a Korean population and effect on glimepiride pharmacokinetics
pp. 105-111(7)
Authors: Lee, H. W.; Lim, M.-s.; Lee, J.; Jegal, M.-Y.; Kim, D.-W.; Lee, W.-K.; Jang, I.-J.; Shin, J.-G.; Yoon, Y.-R.

Influence of leukotriene pathway polymorphisms on clinical responses to montelukast in Japanese patients with asthma
pp. 112-116(5)
Authors: Kotani, H.; Kishi, R.; Mouri, A.; Sashio, T.; Shindo, J.; Shiraki, A.; Hiramatsu, T.; Iwata, S.; Taniguchi, H.; Nishiyama, O.; Iwata, M.; Suzuki, R.; Gonda, H.; Niwa, T.; Kondo, M.; Hasegawa, Y.; Kume, H.; Noda, Y.

Eternacept for the treatment of patients with rheumatoid arthritis and concurrent interstitial lung disease
pp. 117-121(5)
Authors: Horai, Y.; Miyamura, T.; Shimada, K.; Takahama, S.; Minami, R.; Yamamoto, M.; Suematsu, E.

Glucocorticoids as a novel approach to the treatment of disabling side effects of sodium stibogluconate
pp. 122-123(2)
Authors: Brostoff, J. M.; Lockwood, D. N.